随机与目标性尿液药物检测在长期接受阿片类药物治疗癌症疼痛患者中的应用。
Random vs Targeted Urine Drug Testing Among Patients Undergoing Long-term Opioid Treatment for Cancer Pain.
机构信息
Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Department of Oncology and Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
出版信息
JAMA Oncol. 2020 Apr 1;6(4):580-581. doi: 10.1001/jamaoncol.2019.6756.
Abstract
This cohort study assesses the frequency of abnormal urine drug test findings among patients with cancer pain treated with long-term opioid therapy who underwent random and targeted testing.
摘要
本队列研究评估了长期接受阿片类药物治疗的癌症疼痛患者在进行随机和靶向检测时尿液药物检测异常结果的频率。
相似文献
1
Random vs Targeted Urine Drug Testing Among Patients Undergoing Long-term Opioid Treatment for Cancer Pain.随机与目标性尿液药物检测在长期接受阿片类药物治疗癌症疼痛患者中的应用。
JAMA Oncol. 2020 Apr 1;6(4):580-581. doi: 10.1001/jamaoncol.2019.6756.
2
Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.门诊支持性护理诊所中接受慢性阿片类药物治疗的晚期癌症患者尿液药物检测的频率、预测因素及结果
Cancer. 2016 Dec 1;122(23):3732-3739. doi: 10.1002/cncr.30240. Epub 2016 Aug 10.
3
The role of opioid analgesia in treating chronic pain.阿片类镇痛在治疗慢性疼痛中的作用。
Br J Hosp Med (Lond). 2017 Sep 2;78(9):C130-C134. doi: 10.12968/hmed.2017.78.9.C130.
4
Random urine drug testing among patients receiving opioid therapy for cancer pain.癌症疼痛接受阿片类药物治疗患者的随机尿液药物检测。
Cancer. 2021 Mar 15;127(6):968-975. doi: 10.1002/cncr.33326. Epub 2020 Nov 24.
5
Opioids for cancer pain: A growing quandary: Opioid prescriptions for cancer-related pain are facing greater scrutiny amid the nation's spiraling epidemic.用于癌症疼痛的阿片类药物：日益棘手的难题：在美国阿片类药物滥用问题不断蔓延的情况下，用于癌症相关疼痛的阿片类药物处方正面临更严格的审查。
Cancer Cytopathol. 2019 Jun;127(6):347-348. doi: 10.1002/cncy.22153.
6
Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain.癌症疼痛患者阿片类药物治疗依从性的临床特征和人口学差异。
Pain Med. 2018 Jul 1;19(7):1469-1477. doi: 10.1093/pm/pnx178.
7
Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.临床医生对接受阿片类药物治疗慢性疼痛患者异常尿液药物检测结果的反应。
Clin J Pain. 2019 Jan;35(1):1-6. doi: 10.1097/AJP.0000000000000652.
8
Toxicology in Pain Management.疼痛管理中的毒理学
Clin Lab Med. 2016 Dec;36(4):673-684. doi: 10.1016/j.cll.2016.07.007. Epub 2016 Oct 15.
9
Single-patient multiple crossover studies to determine the effectiveness of paracetamol in relieving pain suffered by patients with advanced cancer taking regular opioids: A pilot study.单患者多次交叉研究以确定对服用常规阿片类药物的晚期癌症患者使用扑热息痛缓解疼痛的有效性：一项试点研究。
Palliat Med. 2016 Sep;30(8):800-2. doi: 10.1177/0269216316635012. Epub 2016 Mar 1.
10
Opioid addiction and misuse in adult and adolescent patients with cancer.癌症成年和青少年患者中的阿片类药物成瘾及滥用问题
Intern Med J. 2017 Jun;47(6):632-636. doi: 10.1111/imj.13449.
引用本文的文献
1
Reliability of urine drug testing among patients on buprenorphine transdermal patch.丁丙诺啡透皮贴剂治疗患者尿液药物检测的可靠性
Palliat Support Care. 2024 Aug;22(4):822-824. doi: 10.1017/S147895152300086X.
2
Health Care Provider Attitudes and Beliefs Toward Nonmedical Opioid Use in Patients with Cancer Pain.卫生保健提供者对癌症疼痛患者非医疗性阿片类药物使用的态度和信念。
J Palliat Med. 2023 Feb;26(2):248-252. doi: 10.1089/jpm.2022.0293. Epub 2022 Dec 7.
3
Interdisciplinary intervention for the management of nonmedical opioid use among patients with cancer pain.跨学科干预措施用于管理癌症疼痛患者的非医疗用阿片类药物使用。
Cancer. 2022 Oct;128(20):3718-3726. doi: 10.1002/cncr.34392. Epub 2022 Aug 23.
4
A systematic review of assessment approaches to predict opioid misuse in people with cancer.系统评价评估方法预测癌症患者阿片类药物滥用。
Support Care Cancer. 2022 Jul;30(7):5645-5658. doi: 10.1007/s00520-022-06895-w. Epub 2022 Feb 15.
5
Managing Nonmedical Opioid Use Among Patients With Cancer Pain During the COVID-19 Pandemic Using the CHAT Model and Telehealth.在新冠疫情期间，使用CHAT模型和远程医疗管理癌症疼痛患者的非医疗阿片类药物使用情况
J Pain Symptom Manage. 2021 Jul;62(1):192-196. doi: 10.1016/j.jpainsymman.2021.01.005. Epub 2021 Jan 27.
6
Random urine drug testing among patients receiving opioid therapy for cancer pain.癌症疼痛接受阿片类药物治疗患者的随机尿液药物检测。
Cancer. 2021 Mar 15;127(6):968-975. doi: 10.1002/cncr.33326. Epub 2020 Nov 24.
7
Health Care Provider Attitudes, Beliefs, and Perceived Confidence in Managing Patients With Cancer Pain and Nonmedical Opioid Use.医疗服务提供者对管理癌症疼痛患者和非医疗性阿片类药物使用的态度、信念及感知信心。
J Pain Symptom Manage. 2021 Jan;61(1):128-135.e6. doi: 10.1016/j.jpainsymman.2020.06.040. Epub 2020 Jul 6.
本文引用的文献
1
Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer.平衡癌症患者的阿片类镇痛药与非医疗性阿片类药物使用风险。
Nat Rev Clin Oncol. 2019 Apr;16(4):213-226. doi: 10.1038/s41571-018-0143-7.
2
Outcomes of a Specialized Interdisciplinary Approach for Patients with Cancer with Aberrant Opioid-Related Behavior.癌症伴异常阿片类药物相关行为患者的专门跨学科方法的结果。
Oncologist. 2018 Feb;23(2):263-270. doi: 10.1634/theoncologist.2017-0248. Epub 2017 Oct 11.
3
Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain.癌症疼痛患者阿片类药物治疗依从性的临床特征和人口学差异。
Pain Med. 2018 Jul 1;19(7):1469-1477. doi: 10.1093/pm/pnx178.
4
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
5
Urine drug testing in chronic pain.尿液药物检测在慢性疼痛中的应用。
Pain Physician. 2011 Mar-Apr;14(2):123-43.
6
Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain.在使用阿片类药物治疗慢性非癌性疼痛的退伍军人中，临床确诊的阿片类药物滥用和依赖的风险因素。
Pain. 2007 Jun;129(3):355-362. doi: 10.1016/j.pain.2007.02.014. Epub 2007 Apr 20.
Zotero 插件